{
    "title": "Individual feed for https://seekingalpha.com/feed.xml",
    "link": "https://seekingalpha.com/feed.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-23T11:01:13.271885",
    "items": [
        {
            "title": "Sphere Entertainment: High Short Interest And A Promising Outlook",
            "link": "https://seekingalpha.com/article/4855397-sphere-entertainment-high-short-interest-and-a-promising-outlook?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-23T15:55:38",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "3 Old School CEFs That Consistently Beat The Market",
            "link": "https://seekingalpha.com/article/4855395-3-old-school-cefs-that-consistently-beat-the-market?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-23T15:51:54",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Braze: The Rebound Is Just Beginning As Revenue Accelerates",
            "link": "https://seekingalpha.com/article/4855393-braze-the-rebound-is-just-beginning-as-revenue-accelerates?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-23T15:45:23",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Zebra Technologies: Deep Value And Positive Market Outlook",
            "link": "https://seekingalpha.com/article/4855392-zebra-technologies-deep-value-and-positive-market-outlook?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-23T15:43:42",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Palvella Therapeutics: Phase 2 Success De-Risks 2026 Catalyst",
            "link": "https://seekingalpha.com/article/4855391-palvella-therapeutics-phase-2-success-de-risks-2026-catalyst?source=feed_all_articles",
            "description": "",
            "pubDate": "2025-12-23T15:43:39",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        }
    ]
}